我们的见解
From Fragmented Resources to National Integration: A Strategic Pathway and Implementation Framework for the Transformation of Taiwan’s Biotechnology Industry
Amid the ongoing reshaping of global geopolitics and intensifying competition in the biotechnology sector, Taiwan’s biotech industry stands at a critical inflection point—shifting from a “technology-driven” model toward a...
From Fragmented Resources to National Integration: A Strategic Pathway and Implementation Framework for the Transformation of Taiwan’s Biotechnology Industry
Amid the ongoing reshaping of global geopolitics and intensifying competition in the biotechnology sector, Taiwan’s biotech industry stands at a critical inflection point—shifting from a “technology-driven” model toward a...
Challenges and Strategic Reflections on Taiwan’s Biotechnology Industry
Challenges and Strategic Reflections on Taiwan’s Biotechnology Industry Amid accelerating deglobalization and intensifying geopolitical tensions, Taiwan’s biotechnology industry confronts structural constraints that limit its strategic positioning within the reconfigured global...
Challenges and Strategic Reflections on Taiwan’s Biotechnology Industry
Challenges and Strategic Reflections on Taiwan’s Biotechnology Industry Amid accelerating deglobalization and intensifying geopolitical tensions, Taiwan’s biotechnology industry confronts structural constraints that limit its strategic positioning within the reconfigured global...
The New Landscape of Southeast Asian Biotech and Healthcare in a Multipolar Era
— Key Opportunities and Localized Solutions for Taiwan’s Biotech Industry As the momentum of globalization slows and the structure of single-power dominance loosens, the international order in 2026 is accelerating...
The New Landscape of Southeast Asian Biotech and Healthcare in a Multipolar Era
— Key Opportunities and Localized Solutions for Taiwan’s Biotech Industry As the momentum of globalization slows and the structure of single-power dominance loosens, the international order in 2026 is accelerating...
The 2026 Pharmaceutical Paradigm Shift: China’s Global Ambitions Post-Drug Regulation Reform and the Challenges for Taiwan
On December 31, 2025, the State Council Executive Meeting officially reviewed and approved the "Regulations for the Implementation of the Drug Administration Law of the People's Republic of China (Revised Draft)"...
The 2026 Pharmaceutical Paradigm Shift: China’s Global Ambitions Post-Drug Regulation Reform and the Challenges for Taiwan
On December 31, 2025, the State Council Executive Meeting officially reviewed and approved the "Regulations for the Implementation of the Drug Administration Law of the People's Republic of China (Revised Draft)"...
Taiwan Biotech Industry Trend Analysis
Precision Medicine, Digital Innovation, and Global Market Integration In recent years, Taiwan’s biotech industry has gradually shaped a development framework centered on precision medicine, regenerative medicine, AI-enabled drug development, and...
Taiwan Biotech Industry Trend Analysis
Precision Medicine, Digital Innovation, and Global Market Integration In recent years, Taiwan’s biotech industry has gradually shaped a development framework centered on precision medicine, regenerative medicine, AI-enabled drug development, and...
Japan Pharmaceutical Market Entry Strategy
Japan Pharmaceutical Market Entry Strategy #Strategic Overview Japan is not a “get approval, then sell” market. It is a five-ring system that requires synchronized alignment across regulatory license holding,...
Japan Pharmaceutical Market Entry Strategy
Japan Pharmaceutical Market Entry Strategy #Strategic Overview Japan is not a “get approval, then sell” market. It is a five-ring system that requires synchronized alignment across regulatory license holding,...
